ID   GLCTK_HUMAN             Reviewed;         523 AA.
AC   Q8IVS8; Q0P630; Q2EZ43; Q6Y2K6; Q7Z6G5; Q86YR8; Q8TED2; Q8WTY2;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   12-APR-2017, entry version 118.
DE   RecName: Full=Glycerate kinase;
DE            EC=2.7.1.31 {ECO:0000269|PubMed:16753811, ECO:0000269|PubMed:20949620};
DE   AltName: Full=HBeAg-binding protein 4;
GN   Name=GLYCTK; Synonyms=HBEBP4; ORFNames=LP5910;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), SUBCELLULAR
RP   LOCATION(ISOFORMS 1 AND 2), CATALYTIC ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=16753811; DOI=10.1080/10425170500476665;
RA   Guo J.-H., Hexige S., Chen L., Zhou G.-J., Wang X., Jiang J.-M.,
RA   Kong Y.-H., Ji G.-Q., Wu C.-Q., Zhao S.-Y., Yu L.;
RT   "Isolation and characterization of the human D-glyceric acidemia
RT   related glycerate kinase gene GLYCTK1 and its alternatively splicing
RT   variant GLYCTK2.";
RL   DNA Seq. 17:1-7(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7).
RC   TISSUE=Lung;
RA   Guo J.H.;
RT   "Cloning of HCG9886S gene and identification of a novel domain.";
RL   Submitted (NOV-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 6).
RA   Zhang J.-K., Cheng J., Lan X.-Y., Guo J., Zhang L.-Y.;
RT   "Screening and cloning of HBeAg binding protein 4.";
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Lung, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   KINETIC PARAMETERS, CATALYTIC ACTIVITY, VARIANT D-GA CYS-493, AND
RP   CHARACTERIZATION OF VARIANT D-GA CYS-493.
RX   PubMed=20949620; DOI=10.1002/humu.21375;
RA   Sass J.O., Fischer K., Wang R., Christensen E., Scholl-Burgi S.,
RA   Chang R., Kapelari K., Walter M.;
RT   "D-glyceric aciduria is caused by genetic deficiency of D-glycerate
RT   kinase (GLYCTK).";
RL   Hum. Mutat. 31:1280-1285(2010).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-60, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CATALYTIC ACTIVITY: ATP + D-glycerate = ADP + 3-phospho-D-
CC       glycerate. {ECO:0000269|PubMed:16753811,
CC       ECO:0000269|PubMed:20949620}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.1 mM for D-glycerate {ECO:0000269|PubMed:20949620};
CC   -!- INTERACTION:
CC       Q13137:CALCOCO2; NbExp=3; IntAct=EBI-748515, EBI-739580;
CC       Q4ZH49:DTX2; NbExp=3; IntAct=EBI-748515, EBI-10192429;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-748515, EBI-618309;
CC       Q53G59:KLHL12; NbExp=3; IntAct=EBI-748515, EBI-740929;
CC       P19012:KRT15; NbExp=3; IntAct=EBI-748515, EBI-739566;
CC       Q93062:RBPMS; NbExp=3; IntAct=EBI-748515, EBI-740322;
CC       Q04864:REL; NbExp=3; IntAct=EBI-748515, EBI-307352;
CC       Q8IYX7:SAXO1; NbExp=3; IntAct=EBI-748515, EBI-3957636;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-748515, EBI-719493;
CC       A1L4B6:TRIM42; NbExp=3; IntAct=EBI-748515, EBI-10172216;
CC       Q15645:TRIP13; NbExp=8; IntAct=EBI-748515, EBI-358993;
CC       Q9UGJ1:TUBGCP4; NbExp=3; IntAct=EBI-748515, EBI-1052544;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cytoplasm
CC       {ECO:0000269|PubMed:16753811}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm. Mitochondrion
CC       {ECO:0000269|PubMed:16753811}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=Glycerate kinase 1 {ECO:0000303|PubMed:16753811},
CC       GLYCTK1 {ECO:0000303|PubMed:16753811};
CC         IsoId=Q8IVS8-1; Sequence=Displayed;
CC       Name=2; Synonyms=Glycerate kinase 2 {ECO:0000303|PubMed:16753811},
CC       GLYCTK2 {ECO:0000303|PubMed:16753811};
CC         IsoId=Q8IVS8-2; Sequence=VSP_025360, VSP_025362;
CC       Name=3;
CC         IsoId=Q8IVS8-3; Sequence=VSP_025358;
CC       Name=4;
CC         IsoId=Q8IVS8-4; Sequence=VSP_025363, VSP_025365;
CC       Name=5;
CC         IsoId=Q8IVS8-5; Sequence=VSP_025357, VSP_025364, VSP_025365;
CC       Name=6;
CC         IsoId=Q8IVS8-6; Sequence=VSP_025356;
CC       Name=7;
CC         IsoId=Q8IVS8-7; Sequence=VSP_025359, VSP_025361;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:16753811}.
CC   -!- DISEASE: D-glyceric aciduria (D-GA) [MIM:220120]: A rare metabolic
CC       disease characterized by chronic metabolic acidosis and a highly
CC       variable clinical phenotype. Clinical features range from an
CC       encephalopathic presentation with seizures, microcephaly, severe
CC       mental retardation and early death, to milder manifestations with
CC       only speech delay or even normal development.
CC       {ECO:0000269|PubMed:20949620}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycerate kinase type-2 family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH36862.1; Type=Frameshift; Positions=177; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY295075; AAP51132.1; -; mRNA.
DR   EMBL; AF448855; AAP41923.1; -; mRNA.
DR   EMBL; AY172690; AAO17719.1; -; mRNA.
DR   EMBL; AY189286; AAO86730.1; -; mRNA.
DR   EMBL; AK074215; BAB85018.1; -; mRNA.
DR   EMBL; AY134474; AAM95456.1; -; mRNA.
DR   EMBL; DQ352863; ABD22985.1; -; mRNA.
DR   EMBL; BC021896; AAH21896.1; -; mRNA.
DR   EMBL; BC036862; AAH36862.1; ALT_FRAME; mRNA.
DR   EMBL; BC042151; AAH42151.1; -; mRNA.
DR   CCDS; CCDS2852.1; -. [Q8IVS8-1]
DR   CCDS; CCDS46841.1; -. [Q8IVS8-2]
DR   RefSeq; NP_001138423.1; NM_001144951.1. [Q8IVS8-2]
DR   RefSeq; NP_660305.2; NM_145262.3. [Q8IVS8-1]
DR   UniGene; Hs.415312; -.
DR   ProteinModelPortal; Q8IVS8; -.
DR   SMR; Q8IVS8; -.
DR   BioGrid; 126307; 14.
DR   IntAct; Q8IVS8; 63.
DR   MINT; MINT-1440661; -.
DR   STRING; 9606.ENSP00000389175; -.
DR   iPTMnet; Q8IVS8; -.
DR   PhosphoSitePlus; Q8IVS8; -.
DR   BioMuta; GLYCTK; -.
DR   DMDM; 74728080; -.
DR   EPD; Q8IVS8; -.
DR   MaxQB; Q8IVS8; -.
DR   PaxDb; Q8IVS8; -.
DR   PeptideAtlas; Q8IVS8; -.
DR   PRIDE; Q8IVS8; -.
DR   DNASU; 132158; -.
DR   Ensembl; ENST00000305690; ENSP00000301965; ENSG00000168237. [Q8IVS8-2]
DR   Ensembl; ENST00000436784; ENSP00000389175; ENSG00000168237. [Q8IVS8-1]
DR   Ensembl; ENST00000473032; ENSP00000418951; ENSG00000168237. [Q8IVS8-7]
DR   Ensembl; ENST00000477382; ENSP00000419008; ENSG00000168237. [Q8IVS8-2]
DR   GeneID; 132158; -.
DR   KEGG; hsa:132158; -.
DR   UCSC; uc003ddo.4; human. [Q8IVS8-1]
DR   CTD; 132158; -.
DR   DisGeNET; 132158; -.
DR   GeneCards; GLYCTK; -.
DR   HGNC; HGNC:24247; GLYCTK.
DR   HPA; HPA006913; -.
DR   MalaCards; GLYCTK; -.
DR   MIM; 220120; phenotype.
DR   MIM; 610516; gene.
DR   neXtProt; NX_Q8IVS8; -.
DR   OpenTargets; ENSG00000168237; -.
DR   Orphanet; 941; D-glyceric aciduria.
DR   PharmGKB; PA162389865; -.
DR   eggNOG; KOG3935; Eukaryota.
DR   eggNOG; COG2379; LUCA.
DR   GeneTree; ENSGT00390000014365; -.
DR   HOVERGEN; HBG098351; -.
DR   InParanoid; Q8IVS8; -.
DR   KO; K11529; -.
DR   OMA; THTNVND; -.
DR   OrthoDB; EOG091G0HT4; -.
DR   PhylomeDB; Q8IVS8; -.
DR   TreeFam; TF313770; -.
DR   BRENDA; 2.7.1.31; 2681.
DR   Reactome; R-HSA-70350; Fructose catabolism.
DR   SABIO-RK; Q8IVS8; -.
DR   ChiTaRS; GLYCTK; human.
DR   GenomeRNAi; 132158; -.
DR   PRO; PR:Q8IVS8; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000168237; -.
DR   CleanEx; HS_GLYCTK; -.
DR   ExpressionAtlas; Q8IVS8; baseline and differential.
DR   Genevisible; Q8IVS8; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008887; F:glycerate kinase activity; IDA:UniProtKB.
DR   GO; GO:0061624; P:fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate; TAS:Reactome.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   Gene3D; 3.40.1480.10; -; 1.
DR   InterPro; IPR007835; MOFRL.
DR   InterPro; IPR025286; MOFRL_assoc_dom.
DR   Pfam; PF13660; DUF4147; 1.
DR   Pfam; PF05161; MOFRL; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Disease mutation; Kinase; Mitochondrion; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    523       Glycerate kinase.
FT                                /FTId=PRO_0000287192.
FT   COMPBIAS     94     97       Poly-Ala.
FT   MOD_RES      60     60       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1    336       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:15498874,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_025356.
FT   VAR_SEQ       1    127       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_025357.
FT   VAR_SEQ     119    184       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_025358.
FT   VAR_SEQ     178    205       GGSALLPAPIPPVTLEEKQTLTRLLAAR -> WGTPAAHRD
FT                                DRYQCHGHPPLVPAASVMA (in isoform 7).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_025359.
FT   VAR_SEQ     179    234       GSALLPAPIPPVTLEEKQTLTRLLAARGATIQELNTIRKAL
FT                                SQLKGGGLAQAAYPA -> EPHPVRCGGGPCGGDCQWPHRG
FT                                QFPQCARLPAYPQSLRPPCSPATFCEDCAVSGRL (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:16753811}.
FT                                /FTId=VSP_025360.
FT   VAR_SEQ     206    523       Missing (in isoform 7).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_025361.
FT   VAR_SEQ     235    523       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:16753811}.
FT                                /FTId=VSP_025362.
FT   VAR_SEQ     340    367       DVKSMAQFYGLLAHVARTRLTPSMAGAS -> WGTPAAHRD
FT                                DRYQCHGHPPLVPAASVMA (in isoform 4).
FT                                {ECO:0000303|Ref.5}.
FT                                /FTId=VSP_025363.
FT   VAR_SEQ     340    367       DVKSMAQFYGLLAHVARTRLTPSMAGAS -> WGTPAAHRD
FT                                DRYQCHGHPPIVPAASVMA (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_025364.
FT   VAR_SEQ     368    523       Missing (in isoform 4 and isoform 5).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.5}.
FT                                /FTId=VSP_025365.
FT   VARIANT      27     27       R -> C (in dbSNP:rs34502608).
FT                                /FTId=VAR_061205.
FT   VARIANT     170    170       L -> V (in dbSNP:rs35130772).
FT                                /FTId=VAR_032285.
FT   VARIANT     394    394       T -> I (in dbSNP:rs9813489).
FT                                /FTId=VAR_032286.
FT   VARIANT     493    493       F -> C (in D-GA; the mutant protein is
FT                                not expressed and has no enzymatic
FT                                activity; dbSNP:rs121909448).
FT                                {ECO:0000269|PubMed:20949620}.
FT                                /FTId=VAR_065909.
FT   CONFLICT    144    144       D -> Y (in Ref. 1; AAP51132).
FT                                {ECO:0000305}.
FT   CONFLICT    245    245       V -> E (in Ref. 4; BAB85018).
FT                                {ECO:0000305}.
SQ   SEQUENCE   523 AA;  55253 MW;  CCBEC88E8850FC11 CRC64;
     MAAALQVLPR LARAPLHPLL WRGSVARLAS SMALAEQARQ LFESAVGAVL PGPMLHRALS
     LDPGGRQLKV RDRNFQLRQN LYLVGFGKAV LGMAAAAEEL LGQHLVQGVI SVPKGIRAAM
     ERAGKQEMLL KPHSRVQVFE GAEDNLPDRD ALRAALAIQQ LAEGLTADDL LLVLISGGGS
     ALLPAPIPPV TLEEKQTLTR LLAARGATIQ ELNTIRKALS QLKGGGLAQA AYPAQVVSLI
     LSDVVGDPVE VIASGPTVAS SHNVQDCLHI LNRYGLRAAL PRSVKTVLSR ADSDPHGPHT
     CGHVLNVIIG SNVLALAEAQ RQAEALGYQA VVLSAAMQGD VKSMAQFYGL LAHVARTRLT
     PSMAGASVEE DAQLHELAAE LQIPDLQLEE ALETMAWGRG PVCLLAGGEP TVQLQGSGRG
     GRNQELALRV GAELRRWPLG PIDVLFLSGG TDGQDGPTEA AGAWVTPELA SQAAAEGLDI
     ATFLAHNDSH TFFCCLQGGA HLLHTGMTGT NVMDTHLLFL RPR
//
